➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
McKesson
McKinsey
AstraZeneca

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

DESOXIMETASONE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Desoximetasone, and what generic alternatives are available?

Desoximetasone is a drug marketed by Actavis Mid Atlantic, Akorn, Cadila, Cosette, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising, Acp Nimble, Altana, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Zydus Pharms. and is included in thirty NDAs.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

US ANDA Litigation and Generic Entry Outlook for Desoximetasone

A generic version of DESOXIMETASONE was approved as desoximetasone by PERRIGO NEW YORK on July 1st, 2003.

  Start Trial

Drug patent expirations by year for DESOXIMETASONE
Drug Prices for DESOXIMETASONE

See drug prices for DESOXIMETASONE

Drug Sales Revenue Trends for DESOXIMETASONE

See drug sales revenues for DESOXIMETASONE

Recent Clinical Trials for DESOXIMETASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
SPS MEDICAL CO.,LTD.Phase 3
Siriraj HospitalPhase 3

See all DESOXIMETASONE clinical trials

Recent Litigation for DESOXIMETASONE

Identify potential future generic entrants

District Court Litigation
Case NameDate
TARO PHARMACEUTICALS U.S.A., INC. v. GLENMARK PHARMACEUTICALS LTD.2018-08-08
Taro Pharmaceuticals U.S.A., Inc. v. Perrigo UK FINCO Limited Partnership2015-09-22

See all DESOXIMETASONE litigation

Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Synonyms for DESOXIMETASONE
(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
17-Deoxymethansone
17-Desoximethasone
382-67-2
382D672
4E07GXB7AU
9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone
A 41-304
A 41304
A-41-304
A-41304
AB2000738
AKOS030254657
AS-15787
BDBM50103622
BRN 2228097
C-55186
CAS-382-67-2
CCG-101120
CHEBI:691037
CHEMBL1766
CS-3002
CTK8F9086
D |soxim |tasone
D03697
DB00547
Deoxymethasone
Desossimetasone
Desossimetasone [DCIT]
Desoximetasona
Desoximetasona [INN-Spanish]
Desoximetasone (USP/INN)
Desoximetasone [USAN:USP:INN:BAN]
Desoximetasone pound>>A 41-304 pound>>17-deoxy Dexamethasone pound>>HOE 304
Desoximetasonum
Desoximetasonum [INN-Latin]
Desoxymethasone
DSSTox_CID_25647
DSSTox_GSID_45647
DSSTox_RID_81025
DTXSID3045647
EINECS 206-845-3
Esperson
Flubason
GTPL7067
HMS2052C15
HMS2236H07
HOE 304
HOE-304
HY-17570
Ibaril
J83.644C
MLS000028654
MLS001076073
MLS001424230
NC00370
NCGC00023648-03
NCGC00023648-04
Opera_ID_52
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-
Q-200938
Q385370
Q790
R 2113
R-2113
s5685
SC-46986
SCHEMBL4214
SMR000058856
Stiedex
Topicort
Topicort (TN)
Topicort LP
Topisolon
Tox21_110889
Tox21_110889_1
UNII-4E07GXB7AU
VWVSBHGCDBMOOT-IIEHVVJPSA-N
ZINC4212854
Paragraph IV (Patent) Challenges for DESOXIMETASONE
Tradename Dosage Ingredient NDA Submissiondate
TOPICORT SPRAY;TOPICAL desoximetasone 204141 2013-12-18

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 205206-001 Sep 19, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Atlantis DESOXIMETASONE desoximetasone SPRAY;TOPICAL 208124-001 Mar 16, 2018 AT RX No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic DESOXIMETASONE desoximetasone CREAM;TOPICAL 205082-001 Sep 4, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Altana DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 073440-001 Apr 1, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo Israel DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 077770-001 Apr 20, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Atlantis DESOXIMETASONE desoximetasone CREAM;TOPICAL 208163-001 Jan 10, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
McKesson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.